JP Stock MarketDetailed Quotes

4536 Santen Pharmaceutical

Watchlist
  • 1756.0
  • +7.0+0.40%
20min DelayMarket Closed Sep 20 15:00 JST
639.18BMarket Cap24.26P/E (Static)

Santen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Santen Pharmaceutical Q1 2025 Earnings Date

Currency：JPYAug 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
74.77B
--
+3.29%
EPS
--
29.50
--
+5.92%
Analyst Rating
Buy

Sep 4, 2024

Santen Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 72.998B--
Nov 7, 20242025/Q2-- / 73.880B--
Aug 6, 20242025/Q174.771B / 73.939B--
May 9, 20242024/Q479.132B / 78.097B--
Feb 8, 20242024/Q377.027B / 73.700B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 72.998B--
Nov 7, 20242025/Q2-- / 73.880B--
Aug 6, 20242025/Q174.771B / 73.939B--
May 9, 20242024/Q479.132B / 78.097B--
Feb 8, 20242024/Q377.027B / 73.700B--

Unlock Free Earnings Estimates

Santen Pharmaceutical Earnings Reports

  • Santen Pharmaceutical: March 2025 quarterly earnings report [IFRS] (consolidated)

    Aug 6 02:00 ET

  • Santen Pharmaceutical: Interim report

    Jun 25 20:45 ET

  • Santen Pharmaceutical: Extraordinary Report

    Jun 25 02:57 ET

  • Santen Pharmaceutical: Confirmation letter

    Jun 25 02:46 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 4, 2024

    Buy

    • Strong Buy

      50.00%

    • Buy

      20.00%

    • Hold

      30.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data